NCT04351334
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Pfizer Inc New York, United States
Clinical trial condition
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
NCT04351334
NCT05902260
NCT02927301
NCT04167657
NCT02358473
NCT02855125
NCT04750824
NCT04434482
NCT02864394
Not specified
NCT05002868